Skip to main content
All lobbying filings

NATIONAL KIDNEY FOUNDATION

NATIONAL KIDNEY FOUNDATION filed a Q2 report for NATIONAL KIDNEY FOUNDATION on July 20, 2025.

Lobbying for NATIONAL KIDNEY FOUNDATION

All filings by NATIONAL KIDNEY FOUNDATION · Everything NATIONAL KIDNEY FOUNDATION has reported

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Aug 14, 2025.
 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 20, 2025
Expenses
$90,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New York

Official filing document

 Government bodies contacted 9
 Lobbying activity 3

FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Indian Health Service.

Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).

Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.

 Bills named in this filing 6
  • H.R. 628
    Honor Our Living Donors Act
  • S. 957
    Honor Our Living Donors Act
  • S. 1552
    Living Donor Protection Act of 2025
  • H.R. 1
    One Big Beautiful Bill Act
  • S. 1973
    Treat and Reduce Obesity Act of 2025
  • H.R. 4231
    Treat and Reduce Obesity Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem